| Market Cap | ₹27,447Cr |
| ROE | 8.27% |
| P/E Ratio(TTM) | 34.73 |
| EPS(TTM) | 47.97 |
| P/B Ratio | 2.87 |
| Dividend Yield | 1.08% |
| Industry P/E | 33.18 |
| Book Value | 580.41 |
| Debt to Equity | 0.03 |
| Face Value | 1 |
| Parent Organisation | Gland Pharma Limited |
| Managing Director | Srinivas Sadu |
| Founded | 1978 |
| NSE Symbol | GLAND |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 59.46 | ||
| Ajanta Pharma | NA (0.00%) | 33.38 | ||
| Eris Lifesciences | NA (0.00%) | 47.12 | ||
| Sai Life Sciences | NA (0.00%) | 64.34 |